Mitovation, Inc
Mitovation, Inc., based in Ann Arbor, MI, is a pioneering company specializing in noninvasive therapeutic devices that utilize inhibitory wavelengths of near-infrared light to mitigate ischemia reperfusion injuries in the brain, particularly following cardiac arrest, stroke, or traumatic brain injury. The company's technology is supported by robust scientific research, multiple patents, and an experienced leadership team with a strong background in translating medical devices from bench to bedside.
With a focus on safety and efficacy, Mitovation's infrared light technology has been recognized as a Class II medical device and is undergoing large animal studies funded by the National Institutes of Health and Department of Defense. The company aims to address multiple markets through its innovative Non-Invasive Mitochondrial Modulation Therapy, which seeks to protect neurological function in affected animals and potentially translate those findings into human applications.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
